Fledgling biotech firm Hurel this week said that the Schering Plough Research Institute, will join what it calls a “joint scientific collaboration” to help it further develop and test its microfluidics-based “human-on-a-chip” cell-based assay technology for drug discovery.
 
Schering is the second big pharma to become a partner since Hurel introduced the technology in early 2005 and began seeking early-access partners to help bring it to market. The first, penned in early 2005, was Johnson & Johnson.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A draft bill released by the US House of Representatives appropriations committee would increase the 2019 National Institutes of Health budget by 3 percent.

Bloomberg looks into privacy issues raised by law enforcement's use of genetic genealogy sites.

NBC News reports on the Earth BioGenome Project, which aims to sequence all eukaryotic life on Earth.

In Science this week: environmental DNA can help in studies of marine animals, and more.